“showed a trend”

Furthermore, MK-7 supplementation showed a trend regarding distensibility (pre/peri −4.9 ± 21.8; post +2.8 ± 30.8; p = 0.037) and compliance (pre/peri −7.4 ± 21.4; post +2.2 ± 30.8, p = 0.020).

The relative, AR modeled VLF showed a trend toward significant divergence between cohorts (ANOVA q = 0.142), potentially driven by the comparison of controls to CKD/T2DM patients (adj. p = 0.037, Supplementary Table S7 ).

A total of 144 patients were eligible for radiomic analysis, and two grey-level zone-length matrix derived parameters obtained from the iliac crests showed a trend for higher values in the BMBx-positive group compared to the BMBx-negative group (mean 436.6 ± 449.0 versus 227.2 ± 137.8, unadjusted p = 0.037 for high grey-level zone emphasis; mean 308.8 ± 394.4 versus 135.7 ± 97.2, unadjusted p = 0.048 for short-zone high grey-level emphasis), but statistical significance was not found after multiple comparison correction.

As expected, the follow-up demonstrated that patients with mild preoperative RD showed a trend to lower long-term survival compared with normal preoperative renal function patients (96.2% vs 93.1%, p = 0.037).

Indeed, KO showed a trend for 25% decreased Slc2a2 expression (−1.3-fold change; p = 0.037).

Participants in the Q3 also showed a trend toward risk reduction (OR 0.57, 95% CI 0.34–0.97, p = 0.037).

Low ketone body, L-carnitine-treated patients also showed a trend toward lower 1 year mortality than any other group (chi square p = 0.038).

In contrast, ACT significantly improved or showed a trend towards improved outcomes in patients with aggressive biological features, such as PNI (DFS p = 0.038), poorly differentiated histology ( Figure 4 ), and LVI (OS p = 0.057).

We found all genotypes both in congenital and acquired infection, although genotype 4b showed a trend toward a higher prevalence among noncongenital patients ( P = .038), suggesting a reduced ability of this type to be transmitted in utero.

Similarly, the proportion of stromal tissue, glandular luminal space, and vasculature did not significantly correlate with the DL‐based risk scores (Figure 3 and supplementary material, Figure S4 ), whereas the percentage of necrosis showed a trend towards a positive correlation with DL‐based risk scores ( p = 0.038, q = 0.150; Figure 3B,C ).

1.7%) and showed a trend toward improved median OS (9.8 months vs. 9.3 months; HR, 0.83; 95% CI, 0.68–1.02; P=0.038).

The only subset that showed a trend (p=0.038) of increase in healthy donors over age 40 was Tim-3 + B cells ( Figure 3F ).

The mAb A32–CD4 angles showed a trend toward larger values compared with mAb 2G12–CD4 angles ( P = 0.038; Wilcoxon–Mann–Whitney U test) but did not survive the multiplicity correction ( Table S1 ).

Contrastingly, for rs2268493 of the OXTR gene, individuals with the minor allele exhibited lower SW (B = −0.145, p = 0.012) and Lp (B = −1.912, p = 0.010) but showed a trend toward higher GE (B = 0.011, p = 0.038) and LE (B = 0.018, p = 0.042).

Language spoken and insurance status, although both associated with treatment choice in crude analyses, were not associated with any particular treatment choice in adjusted analyses, with the exception of Haitian Creole speakers, who were more likely to choose AS than English speakers (OR = 2.4; P = .017) and showed a trend for decreased odds of receiving RP (OR = 0.48; P = .038).

Pearson's correlations showed that the median goRT, SSRT, and the GS rate were significantly correlated with age (Median goRT, r = 0.2606, p = 0.0078; SSRT, r = 0.3703, p = 0.0001; GS%, r = −0.3218, p = 0.0009), and the SS rate showed a trend toward significant correlation with age (SS%, r = 0.2046, p = 0.0382), corrected for multiple comparisons ( p < 0.0083).

In addition, patients showed a trend toward dwelling less in state 2 ( P = 0.0383, g = -0.67).

It also showed a trend towards statistical relation for CPZ-ED with Propanoate (r=-0.253,p=0.039) and Total SCFA (r=-0.253,p=0.039).

Notably, in the 10-day steroid group, caloric asymmetry significantly decreased from 63 ± 35% to 37 ± 35% between the initial examination (1 week) and 12 months ( p = .014; Figure 3 ), while the 3-day steroid group showed a trend toward reduction, from 60 ± 33% to 41 ± 34% ( p = .039; Figure 3 ).

CMS1 group showed a trend towards PFS benefit from aflibercept (median PFS: 6.6 vs. 3.0 months; HR 0.62, 95% CI 0.39–0.98, p = 0.039, q = 0.156), though OS improvement was modest (median OS: 10.7 vs. 7.4 months; HR 0.88, 95% CI 0.57–1.36, p = 0.564).

Blocking both T- and L-type Ca V channels, contributing to ~27% to AP-evoked Ca 2+ at the AIS ( Figure 3 ), significantly reduced the afterdepolarization and showed a trend to reduce the afterhyperpolarization (ADP, p=0.039 and AHP, p=0.055, respectively, two-tailed paired t-tests, n = 5), without affecting other AP properties (p>0.30; Figure 9d and Table 1 ).

Post-hoc pairwise comparison showed a trend for a lower discrimination index after taVNS compared to VNS OFF (mean difference 10,60 (95% CI [0.59;20.60]), p = 0.039, Bonferroni corrected α = 0.016).

Results Individuals with NSLBP showed a trend towards a reduced fractional anisotropy along the left superior cerebellar peduncle compared to healthy controls (p = 0.039).

(family Veillonellaceae ) showed a trend toward reduction during both MCT-KD and placebo diet when compared to baseline diet ( p = 0.039, q = 0.449, Figure 5B ).

Further analysis showed a trend toward a higher detection rate of Lactobacillus in the experimental group than in the control group ( p = 0.039).